What is it about?
This articles goes over the details of how the Pediatric MS patients did in this clinical trial of fingolimod. It reviews in detail Fingolimod when used in Pediatric MS trial, the side effects, any unexpected events and how it helped MS.
Featured Image
Photo by Robert Collins on Unsplash
Why is it important?
This article helps to explain what a pediatric MS patient may experience when they take Fingolimod for MS and what to be on the look out for as it reviews possible side effects.
Perspectives
This is the first completed controlled clinical trial in Pediatric MS that lead to the FDA approving this medication for Pediatric MS.
Mary Rensel
Cleveland Clinic
Read the Original
This page is a summary of: Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS), Pediatric Health Medicine and Therapeutics, November 2019, Taylor & Francis,
DOI: 10.2147/phmt.s220817.
You can read the full text:
Contributors
The following have contributed to this page
